Merz Therapeutics Gmbh
Clinical trials sponsored by Merz Therapeutics Gmbh, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a Botox-Like shot stop migraines before they start? Results expected Mar 2027 (estimated)
- Can an inhaled levodopa ease Parkinson's OFF episodes? a study asks patients. Results expected Aug 2027 (estimated)
-
New shot aims to ease stubborn nerve pain
Symptom relief CompletedThis study tested whether NT 201 injections can reduce pain in adults with long-term nerve pain caused by shingles or a nerve injury. 123 people received either NT 201 or a placebo shot, and researchers tracked their pain levels over 20 weeks. The goal was to see if the treatment…
Phase 2 • Sponsor: Merz Therapeutics GmbH • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Simple decision tree could help stroke patients get faster care for muscle stiffness
Knowledge-focused CompletedThis completed study tested whether a simple decision tree tool can help nurses and physical therapists recognize early signs of spasticity (muscle stiffness) in people who have had a stroke. Researchers compared the tool's accuracy against assessments by specialized doctors. The…
Sponsor: Merz Therapeutics GmbH • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC